Skip to content

Clinical trials

Phase 1/2 Ischemic Stroke trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Stroke Phase: Phase 1/2 Country / region: United States Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20061
20114
20122
20151
20161
20171
20181
20202
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Withdrawn3
Active, not recruiting2
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The University of Texas Health Science Center, Houston2
Andrew Slivka1
Baylor College of Medicine1
Burke Medical Research Institute1
Burke Rehabilitation Hospital1
Clarion Cells, Inc.1
Daiichi Sankyo1
Global Neurosciences Institute1
ImaRx Therapeutics1
NC Medial Research Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Stroke18
Stroke6
Ischemia2
Brain Injuries, Traumatic1
Cerebral Hemorrhage1
Cough1
Deglutition Disorders1
Fever1
Hematoma, Subdural1
Hemorrhage1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.